Acta Biologica Hungarica

, Volume 53, Issue 3, pp 293–298 | Cite as

N-Acetil-L-Cysteine and 2-Amino-2-Thiazoline N-Acetyl-L-Cysteinate as a Possible Cancer Chemopreventive Agents in Murine Models

  • Vitalija ŠimkevičienėEmail author
  • J. Straukas
  • Saulė Uleckienė


The aim of this study was to investigate N-acetyl-cysteine (NAC) and its 2-amino-2-thiazoline salt (NACAT) as potential chemopreventive agents on experimentally induced lung tumours by urethane (U) in mice. Female BALB/c mice were used. U was given by intraperitoneal injections during 2 weeks (single dose - 10 mg/mouse, total - 50 mg/mouse). Mice were treated daily per os with NAC 1/10 LD50, NACAT 1/10 or 1/100 LD50 starting 2 weeks prior U administration, then during U treatment and thereafter for 2 months. The duration of experiment was 4 months. The results showed that NAC (1000 mg/kg) reduced the lung tumour incidence to 30% that of controls, P · 0.05. Most effective of NACAT was 100 mg/kg dose; it reduced an average of lung adenomas per mouse by 26%, P · 0.05, but lower dose (10 mg/kg) was less effective. In order to achieve similar chemopreventive effect (~30%) on mice, it is necessary to use 0.38 mM/kg of NACAT or 6.13 mM/kg of NAC. It means that 16 times less of NACAT is required, if calculated by molar concentration. In general, NAC and NACAT have a moderate chemopreventive effect on lung tumorigenesis induced by urethane in mice.


Cancer chemoprevention N-acetyl-L-cysteine 2-amino-2-thiazoline N-acetyl-L-cysteinate pulmonary adenomas 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    De Flora, S., D’Agostini, F., Izzotti, A., Balansky, R. (1991) Prevention by N-acetylcysteine of benzo[a]pyrene clastogenicity and DNA adducts in rats. Mutation Res. 250, 87–93.CrossRefGoogle Scholar
  2. 2.
    Balansky, R., Izzotti, A., Scatolini, L., D’Agostini, F., De Flora, S. (1996) Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Res. 56, 1642–1647.PubMedGoogle Scholar
  3. 3.
    Cotgreave, I. A. (1997) N-Acetylcysteine: Pharmacological considerations and experimental and clinical applications. Adv. Pharmacol. 38, 205–227.CrossRefGoogle Scholar
  4. 4.
    De Flora, S., Balansky, R., Bennicelli, C., Camoirano, A., D’Agostini, F., Izzotti, A., Cesarone, C. F. (1995) Mechanisms of anticarcinogenesis: the example of N-acetylcysteine. In: Ioannides, C., Lewis, D. F. V. (eds) Drugs, Diet and Disease, Vol. 1. mechanistic Approaches to Cancer, Ellis Horwood, Hemel Hempstead, pp. 151–203.Google Scholar
  5. 5.
    De Flora, S., D’Agostini, F., Masiello, L., Giunciuglio, D., Albini, A. (1996) Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models. Int. J. cance. 67, 842–848.CrossRefGoogle Scholar
  6. 6.
    Sekharam, M., Trotti, A., Cunnick, J. M., Wu, J. (1998) Suppression of fibroblast cell cycle progression in G1 phase by N-acetyl-cysteine. Toxicol. Appl. Pharmacol. 149, 210–216.CrossRefGoogle Scholar
  7. 7.
    Ward, N. E., Fan, G., O’Brian, C. A. (1999) Differential non-redox inhibitory effects of glutathione against protein kinase c isozyme family members. Oncology Report. 6, 307–310.Google Scholar
  8. 8.
    Oikawa, S., Yamada, K., Yamashita, N., Tada-Oikawa, S., Kawanishi, S. (1999) N-Acetylcysteine, a cancer chemopreventive agent, causes oxidative damage to cellular and isolated DNA. Carcinogenesi. 20, 1485–1490.CrossRefGoogle Scholar
  9. 9.
    Liu, M., Wikonkal, N. M., Brach, D. E. (1999) Induction of cyclin-dependent kinase inhibitors and G1 prolongation by the chemopreventive agent N-acetylcysteine Carcinogenesis 20, 1869–1872.CrossRefGoogle Scholar
  10. 10.
    Pine, M. J., Mirand, E. A., Ambrus, J. L., Bock, F. G. (1983) Antitumor studies of 2-amino-2-thia-zoline and other tumor-modifying agents. J. Me. 14, 433–449.Google Scholar
  11. 11.
    Spickett, R. G. W., Moragues, M. J., Vega, N. A., Priato Soto, J. (1975) 2-amino-2-thiazoline and its pharmacologically active acides. Ger. Offen 2, 461, 494 [Chem. Abstr. 83, P179042 d].Google Scholar
  12. 12.
    European Convention for the Protection of Vertebrate Animals for Experimental and Other Scientific Purposes Strasbourg. Council Directive (86/609/EEC), (1986).Google Scholar
  13. 13.
    Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, D.C. (1996), 1–118.Google Scholar
  14. 14.
    Principles of Good Laboratory Practice, Vilnius, (1999), 1–28.Google Scholar
  15. 15.
    OECD Guideline for the testing of chemicals. Acute oral toxicity - acute toxic class method 423, Paris, (1996).Google Scholar
  16. 16.
    Šimkevicienv, V., Straukas, J. (1997) The experimental study in chemoprevention of cancer with 2-amino-2-thiazoline e-formylaminocaproate. In: 1st Int. Congr. of Asia Pacific Ass. of Med. Toxicology and the 5th Iranian Congr. of Toxicology and Poisoning, Tehran, p. 176.Google Scholar
  17. 17.
    Šimkevicienv, V., Straukas, J., Uleckien, S. (2000) Experimental study on anticarcinogenic activity of acetylsalicylic acid and 2-amino-2-thiazoline acetylsalicylate. Medicina (Vilnius) (In Lithuanian) 36, 123–127.Google Scholar
  18. 18.
    Shimkin, M. B., Stoner, G. D. (1975) Lung tumours in mice: application to carcinogenesis bioassay Advan. Cancer Res. 21, 1–58.CrossRefGoogle Scholar
  19. 19.
    Shimkin, M. B., Weisburger, J. H., Weisburger, E. K., Gubareff N., Suntzeff V. (1966) Bioassay on 29 alkylating chemicals by the pulmonary-tumour responds in strain A mice. J. Nat. Cancer Inst. 36, 915–935.Google Scholar
  20. 20.
    De Flora, S., Astengo, M., Serra, D., Bennicelli, C. (1986) Inhibition of urethane-incuced lug tumors in mice by dietary N-acetylcysteine. Cancer Lett. 32, 235–241.CrossRefGoogle Scholar
  21. 21.
    Rodriguez-Burford, C., Lubet, R. A., Eto, I., Juliana, M. M., Kelloff G. J., Grubbs, C. J., Steele, V. E. (1999) Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea induced mammary cancer model. Carcinogenesis 20, 171–76.CrossRefGoogle Scholar

Copyright information

© Akadémiai Kiadó, Budapest 2002

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Vitalija Šimkevičienė
    • 1
    Email author
  • J. Straukas
    • 1
  • Saulė Uleckienė
    • 2
  1. 1.Institute of BiochemistryVilniusLithuania
  2. 2.Lithuanian Oncology CenterVilniusLithuania

Personalised recommendations